05312nam a2200505 i 4500991003947879707536m o d cr nn||||mamaa210624s2018 sz a o 101 0 eng d9783319635408(electronic bk.)3319635409(electronic bk.)9783319635392(print)331963539510.1007/978-3-319-63540-8doib14413504-39ule_instBibl. Dip.le Aggr. DiSTeBA - Sez. Biologiaeng618.123Frontiers in gynecological endocrinology[e-book].Volume 5,Pre-menopause, menopause and beyond /Martin Birkhaeuser, Andrea R. Genazzani, editorsPre-menopause, menopause and beyond[electronic resource]Cham :Springer,[2018]1 online resource (ix, 327 pages) :color illustrationstexttxtrdacontentcomputercrdamediaonline resourcecrrdacarrierISGE Series,2197-8735Includes indexPart I Menopause: symptoms and neuroendocrine impact Intracrinology made menopause possible -- From menopause to aging: endocrine and neuroendocrine biological changes -- Brain impact of sex steroids withdrawall of the menopause -- Climacteric symptoms: importance and management -- Part II Fertility 2016 IMS Recommendations on women?s midlife health,?POI? and menopause hormone therapy (MHT) -- Female infertility and autoimmunity -- Is IVF/ICSI/ET reasonable beyond the female age of 40 years? -- IVF: new developments in patient tailored ovarian stimulation -- Oocyte donation in peri-menopausal and menopausal women -- Part III Thyroid disorders, polycystic ovary and metabolic syndrome Thyroid disorders in climacteric women -- Thyroid function and pregnancy outcome after ART: what is the evidence? -- PCOS: implications of cardio-metabolic dysfunction -- Why Metformin is so important for prevention and treatment in climacteric women? -- Metabolic changes during menopausal trans ition -- Weight and body composition management after menopause -- Part IV Bone and cardiovascular impact Healthy bones after menopause? what has to be done? -- The effect of menopause and HRT on coronary heart disease -- How to prevent cardiovascular disorders: influence of gonadal steroids on the heart -- Part V Benign breast diseases, BRCA mutation and breast cancer Risk reducing surgery and treatment of menopausal symptoms in BRCA mutation carriers (and other high risk women) -- Benign breast disease during women?s life -- Treatment of menopausal symptoms in breast cancer survivors -- Myo-inositol and Inositol Hexaphosphate (IP6) in the treatment of breast cancer -- Part VI Menopause symptoms: the therapies The true risks of hormone replacement therapy -- Menopausal hormone therapy customization -- Vulvovaginal atrophy (VVA) and Genitourinary Syndrome of Menopause (GSM): Advances in management -- Menopause symptoms: new treatment options -- Intravaginal DHEA for the treatment of vaginal atrophy closest to physiology -- Part VII Surgical challenges after menopause: problems and solutions Bladder dysfunction and urinary incontinence after the menopause: hormones, drugs or surgery? -- When is ovarectomy and when tubectomy indicated at necessary hysterectomies beyond the reproductive age? -- Pelvic floor reconstructive surgery in ageing women: tailoring the treatment to each woman?s needsThis volume represents an up-to-date overview on pre-Menopause and Menopause, with their respective clinical implications and therapies. The aim is to clarify possible doubts and clinical approaches to this particular period in a woman?s life and how to face it, both offering solutions to actual problems and focusing on the potential impact of preventive medicine in improving women?s health and quality of life. The volume is published within the International Society of Gynecological Endocrinology (ISGE) Series, and is based on the 2017 International School of Gynecological and Reproductive Endocrinology Winter Course. This book, covering a very wide range of topics with particular focus on fertility in pre- and peri-menopausal women, climacteric and menopausal symptoms, impact of PCOS on post-menopausal health, breast disease, surgical treatments and therapies, will be an invaluable tool for gynecologists, endocrinologists, and experts in women's healthEndocrine gynecologyReproductive healthMenstruation DisturbancesphysiopathologyPrimary Ovarian InsufficiencytherapyMenopausephysiologyReproductive HealthBirkhaeuser, MartineditorGenazzani, Andrea R.editorInternational School of Gynecological and Reproductive EndocrinologyPrint version:9783319635392ISGE series2197-8735SpringerLinkConnect to resourcehttp://link.springer.com/10.1007/978-3-319-63540-8.b1441350403-03-2224-06-21991003947879707536Frontiers in Gynecological Endocrinology1520323UNISALENTOle00324-06-21m@ -engsz 0004709nam 22007815 450 991036725190332120240314161629.09783030221539303022153910.1007/978-3-030-22153-9(CKB)4100000009758963(MiAaPQ)EBC5971298(DE-He213)978-3-030-22153-9(PPN)24860337X(Perlego)3494680(EXLCZ)99410000000975896320191102d2020 u| 0engurcnu||||||||txtrdacontentcrdamediacrrdacarrierAll the Brains in the Business The Engendered Brain in the 21st Century Organisation /by Kate Lanz, Paul Brown1st ed. 2020.Cham :Springer International Publishing :Imprint: Palgrave Macmillan,2020.1 online resource (160 pages) illustrationsThe Neuroscience of Business,2946-21699783030221522 3030221520 Includes bibliographical references and index.Chapter 1 Brain Sex and Biological Sex -- Chapter 2 Conditions for Optimal Brain Function -- Chapter 3 Survive, Thrive and Flow -- Chapter 4 Brain-Sex Based Attention and Communication -- Chapter 5 Power, Politics and Pressure -- Chapter 6 Problem Solvers and Solution Seekers - the Difference between Intra- Compared with Inter- Neural Connectivity -- Chapter 7 The Beginnings of a New Motivational Theory, from the Engendered Brain -- Chapter 8 The Business Case for Valuing Brain Sex Difference -- Chapter 9 How to Ignite All the Brains in the Business -- Chapter 10 Exhaustion, Energy and Excellence - The Male-Female Differences -- Chapter 11 Creating the Mind of the Organisation -- Chapter 12 The New Organisational Paradigm.The power of gender difference, not gender equality, is a secret source for success. Some smart businesses are starting to wake up to this fact. This book explores why and how. Properly valuing brain gender diversity in the workplace is one of the biggest and largely untapped sources of competitive advantage for modern businesses. Recent advances in neuroscience provide the key to unlocking it. Modern research shows that there are gender-based differences in the brain - it's just not as simple as a binary between a 'male brain' and 'female brain'. In fact, our brains are like a mosaic where many of the tiles are available in thousands of shades on a spectrum between pink and blue. The problem is that our workplaces tend to be governed by structures, processes and cultures that are practically pure blue. All the brains in the business that are elsewhere on the spectrum cannot thrive as they might, so sources of productivity, creativity and agility go untapped. Anyone who manages people needs to understand how the brain works and the impact it has on how people work together as teams. Anyone who wants to unlock the talent and productivity of all of their people needs to understand how recent findings around male- and female-type brains should shape the way they manage. Leading applied neuroscientists and international corporate coaches Kate Lanz and Paul Brown show you why and how to access all the brains in your business.The Neuroscience of Business,2946-2169BusinessManagement scienceDiversity in the workplaceStrategic planningLeadershipNeurosciencesPsychology, IndustrialBusiness and ManagementDiversity Management and Women in BusinessBusiness Strategy and LeadershipNeuroscienceWork and Organizational PsychologyBusiness.Management science.Diversity in the workplace.Strategic planning.Leadership.Neurosciences.Psychology, Industrial.Business and Management.Diversity Management and Women in Business.Business Strategy and Leadership.Neuroscience.Work and Organizational Psychology.650.1082338.7082Lanz Kateauthttp://id.loc.gov/vocabulary/relators/aut967160Brown Paulauthttp://id.loc.gov/vocabulary/relators/autMiAaPQMiAaPQMiAaPQBOOK9910367251903321All the Brains in the Business2195625UNINA